Tue, Sep 23, 2014, 12:49 PM EDT - U.S. Markets close in 3 hrs 11 mins

Recent

% | $
Quotes you view appear here for quick access.

Achillion Pharmaceuticals, Inc. (ACHN) Message Board

  • bergycb bergycb Aug 18, 2014 8:16 AM Flag

    If buyout was imminent, or competitive drug approval was coming, why would ex CEO sell 4 mill $

    In shares on fri? Makes no sense. In fact doesnt even pass the laugh test. Good luck, do your DD

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • the lone SHORT DONKEY !! Heck even sidejerk finally threw in the towel and admitted he was wrong but I guess you know better then everyone else here huh PUNK ??? By all means continue holding that short it'll cost you that much more to cover higher. As far Kisbach selling, heck that rufus MCdufus is nothing more then a hood ornament at this point !!

    • why don't you do some DD. WE understand that ACHN is tied some what to Gilead. Some peoples are winners and can take speculation and other are CAUGHT with their pants down and 35% SHORT..........COVER FOOL... ........ RBC Capital Markets analyst Michael Yee wrote in a research note Friday that while Roche was seen as unlikely to win, the new arbitration panel ruling in favor of Gilead removed a scenario potentially much more disastrous than any other lawsuits Gilead is facing.

    • That guy is 70+ years old and he is just a dummy director. He don't want to wait for another day.

      These analysts are positive not because of any favor, rather they see the execution by the company.

      This is a multi-billion $ drug potential, which is proving to be a very successful one. 12/12, did you see the result like these from any experimental drug?

      GL!

      Sentiment: Strong Buy

 
ACHN
11.21+0.15(+1.36%)12:48 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.